The Tokyo Research Park is principally engaged in research into biopharmaceutical and next-generation drug development. The aim here is to explore the new drug targets and create antibody development candidates.
Mission: Carrying out discovery research and the early development of therapeutic antibodies.
The Antibody Research Laboratories have already made great achievements such as the invention of POTELLIGENT®, the innovative technology which greatly enhances the action of antibodies. The laboratories will continue to create new development candidates through both their independent research and external joint research ventures.
Mission: Creation of new development candidates and discovery research of drug targets, through the utilization of the strengths of chromosome engineering, cellular immunology, nephrology and natural product chemistry.
The Innovative Drug Research Laboratories are a research organization pursuing the possibilities of biotechnology. New possibilities are being opened up for biotechnology through utilizing the strengths of chromosome engineering, cellular immunology, nephrology and the natural product chemistry in an independent innovative and active research environment, where each researcher can make use of their creative imagination and inexhaustible drive for knowledge.